News

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...
Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be ...
Semaglutide, the blockbuster drug better known by brand names like Ozempic and Wegovy, has now shown significant promise in ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...